ClinicalTrials.Veeva

Menu

Prevalence of Amyloidosis in Trauma Patients (APTUR)

C

Consorci Sanitari de l'Alt Penedès i Garraf

Status

Enrolling

Conditions

Amyloidosis

Treatments

Procedure: Traumatologic surgery

Study type

Observational

Funder types

Other

Identifiers

NCT06527521
CSAPG-61

Details and patient eligibility

About

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Enrollment

246 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
  • Ability to cooperate in the necessary evaluations.
  • Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion criteria

- Participants previously diagnosed with amyloidosis cannot be included in the study.

Trial contacts and locations

1

Loading...

Central trial contact

Lidia Tikhomirova, MD; Noemí Casaponsa

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems